-
Report details
-
52
Figures
-
55
Tables
-
Chapter 1: Executive Summary
-
Overview
-
Scope and Methodology
-
Size and Growth of the Market
-
Chapter 2: Middle East and Africa: Regional Overview
-
Overview
-
Regional Market Overview
-
Population
-
Major Diseases Affecting the Middle Eastern / African Population
-
Cardiovascular Diseases
-
Cancer
-
Diabetes
-
Middle Eastern Respiratory Syndrome (MERS)
-
SARS-CoV-2 (COVID-19)
-
Chapter 3: Egypt IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 4: Iran IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Chapter 5: Iraq IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 6: Israel IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 7: Jordan IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Chapter 8: Saudi Arabia IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 9: South Africa IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
Ebola Outbreaks
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 10: Turkey IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 11: United Arab Emirates (UAE) IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 12: Total Mideast & Africa IVD Market
-
Overview
-
Summary
-
Clinical Chemistry Market
-
Immunoassay Market
-
Microbiology Market
-
Point-of-Care Market
-
Histology Market
|
In Vitro Diagnostics (IVD) in the Middle East and Africa
27 May 2022
There has been an increasing standard of living in the Middle East and Africa due to higher national income. This has contributed to a higher incidence of heart disease - high blood pressure, high cholesterol and high blood sugar. In fact, the Middle East/Africa region is one of the higher areas for heart disease which has prompted more individuals being admitted to the hospital. This has caused an uptick in the demand for diagnostic testing devices and medical devices.
This report provides an overview of developments in the in vitro diagnostics industry in the Middle East and Africa. The countries covered are
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates (UAE)
- Other Mideast (Bahrain, Cyprus, Gaza Strip, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen)
- Other Africa (Algeria, Congo, Sudan, Libya, Chad, Niger, Angola, Mali, Ethiopia, etc.)
Scope
The Middle East, Africa market for in vitro diagnostics is provided in U.S. dollars for the years 2021 – 2026.
The report covers six segments of the IVD market in the Middle East:
- Clinical Chemistry
- Immunoassay
- Microbiology
- Point of Care (POC)
- Histology – traditional stains
- Other (includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests and other areas not covered specifically in the above segments)
Page Count: 102
Table of Contents
-
Chapter 1: Executive Summary
-
Overview
-
Scope and Methodology
-
Size and Growth of the Market
-
Chapter 2: Middle East and Africa: Regional Overview
-
Overview
-
Regional Market Overview
-
Population
-
Major Diseases Affecting the Middle Eastern / African Population
-
Cardiovascular Diseases
-
Cancer
-
Diabetes
-
Middle Eastern Respiratory Syndrome (MERS)
-
SARS-CoV-2 (COVID-19)
-
Chapter 3: Egypt IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 4: Iran IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Chapter 5: Iraq IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 6: Israel IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 7: Jordan IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Chapter 8: Saudi Arabia IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 9: South Africa IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
Ebola Outbreaks
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 10: Turkey IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 11: United Arab Emirates (UAE) IVD Market
-
Overview
-
Market Summary
-
Market Strengths and Weaknesses (Drivers and Inhibitors)
-
COVID-19 Pandemic Situation
-
Market Participant Activity
-
Chapter 12: Total Mideast & Africa IVD Market
-
Overview
-
Summary
-
Clinical Chemistry Market
-
Immunoassay Market
-
Microbiology Market
-
Point-of-Care Market
-
Histology Market
|
More information about this product
Other Users Also Viewed
24 Jun 2020
The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.
Updated June 2020 to reflect the COVID-1…
|